Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Adipocytes"

Article category

Keywords

Publication year

"Adipocytes"

Editorial

Hepatic neoplasm

Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clin Mol Hepatol 2021;27(1):87-90.
Published online December 3, 2020
DOI: https://doi.org/10.3350/cmh.2020.0302

Citations

Citations to this article as recorded by  Crossref logo
  • Systemic hematologic, metabolic, and inflammatory dysregulation in liver cirrhosis and hepatocellular carcinoma: diagnostic utility of novel indices in an Egyptian cohort
    Dalia E. Sherief, Hadeer Hamdy Shehata, Nahla Nosair, Amira A. A. Othman, Mohamed W. Saleh, Emad Sadaka, Rasha Elgamal
    BMC Gastroenterology.2026;[Epub]     CrossRef
  • Integrative transcriptomic analysis reveals miR-26a-5p downregulation and a potential predictive gene signature for the progression of metabolic liver disease
    Andrei Sorop, Alina-Veronica Ghionescu, Diana Larisa Ancuța, Maria-Gabriela Croitoru, Cristin Coman, Daniela Lixandru, Simona Olimpia Dima
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
    Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
    Cancers.2025; 17(4): 566.     CrossRef
  • Biosocial Determinants of Health Among Patients with Chronic Liver Disease and Liver Cancer
    Tagari Samanta, Jun Hyoung Park, Benny Abraham Kaipparettu
    Cancers.2025; 17(5): 844.     CrossRef
  • Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050
    Jianing Shi, Xuan Wu, Jiali Yu, Qingli Zhou
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Large duct primary sclerosing cholangitis with or without inflammatory bowel disease in Saudi patients
    Hamdan S. AlGhamdi, Nawaf M. AlYahya, Ibrahim M. Bahabri, Majed A. Al Ashaikh, Abdulrahman K. Habib, Abdulaziz A. AlAhmary, Nuha Al Ajlan, Abdulrahman I. AlAbdulgader, Abduljaleel M. Alalwan, Faisal M. Sanai
    Saudi Journal of Gastroenterology.2025; 31(6): 356.     CrossRef
  • Non-Viral Hepatocellular Carcinoma with Normal Alpha-Fetoprotein but Elevated CA19-9 in an Older Patient with Obesity: A Case Report
    Seung Hun Lee, Mi Soo Kim, Jeong Gyu Lee
    Korean Journal of Geriatrics & Gerontology.2025; 26(3): 147.     CrossRef
  • Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma
    Alok Raghav, Goo Bo Jeong
    Cells.2024; 13(7): 638.     CrossRef
  • Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes
    Jinyue Tian, Jiao Meng, Zhenkun Yang, Li Song, Xinyi Jiang, Jian Zou
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels
    Zhan Lin, Mei Gan, Xiangping Wang, Zhonghua Su
    Reproductive Health.2024;[Epub]     CrossRef
  • Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques
    Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil
    Cureus.2024;[Epub]     CrossRef
  • Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
    Seren M. Gedallovich, Paul Y. Kwo
    Clinical and Molecular Hepatology.2024; 30(4): 1050.     CrossRef
  • The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
    Yuri Cho, Bo Hyun Kim, Joong-Won Park
    Clinical and Molecular Hepatology.2023; 29(1): 99.     CrossRef
  • Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
    Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
    Clinical and Molecular Hepatology.2023; 29(2): 433.     CrossRef
  • Occurrence of Liver Cancer in People without Traditional Risk Factors
    Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
    Korean Journal of Clinical Geriatrics.2023; 24(1): 41.     CrossRef
  • The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
    K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu
    Advanced Gut & Microbiome Research.2023; 2023: 1.     CrossRef
  • Bursatella leachii Purple Ink Secretion Concentrate Exerts Cytotoxic Properties against Human Hepatocarcinoma Cell Line (HepG2): In Vitro and In Silico Studies
    Zeyad I. Alehaideb, Anuradha Venkatraman, Mahadev Kokane, Syed Ali Mohamed, Saranya Rameshbabu, Rasha S. Suliman, Sahar S. Alghamdi, Hamad Al-Eidi, Bandar Alghanem, Maha-Hamadien Abdulla, Sabine Matou-Nasri
    Molecules.2022; 27(3): 826.     CrossRef
  • The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
    Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
    Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi
    BMC Cancer.2022;[Epub]     CrossRef
  • Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
    Joo Hyun Oh, Je Hee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang
    Nutrients.2021; 13(3): 1013.     CrossRef
  • Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
    Cancers.2021; 13(14): 3424.     CrossRef
  • Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
    Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
    Translational Oncology.2021; 14(9): 101158.     CrossRef
  • Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
    Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
    International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
  • 10,197 View
  • 129 Download
  • 22 Web of Science
  • Crossref